Physicians' views on pharmacists' involvement in hospital deprescribing: A qualitative study on proton pump inhibitors

被引:5
作者
Gendre, Pauline [1 ]
Mayol, Severine [2 ]
Mocquard, Julie [1 ]
Huon, Jean-Francois [1 ,3 ]
机构
[1] Nantes Univ, CHU Nantes, Pharm Dept, Nantes, France
[2] Nantes Univ, Fac Sociol, Nantes, France
[3] SPHERE, INSERM, MethodS Patients Ctr Outcomes & Hlth Res, Nantes, France
关键词
clinical pharmacy; deprescribing; hospital setting; proton pump inhibitors; qualitative research; PRIMARY-CARE; MEDICATION; ADULTS; IMPACT;
D O I
10.1111/bcpt.13878
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BackgroundClinical pharmacists have a pivotal role in the management of the patient's medication. However, it is necessary to know how pharmacist-mediated deprescribing could be implemented in a hospital setting according to hospital physicians. ObjectiveTo explore physicians' views on the involvement of hospital pharmacists in the deprescribing process using the example of PPIs. MethodsA qualitative study using two focus groups with hospital physicians was conducted to determine their attitudes regarding deprescribing initiated by the hospital pharmacist. The interviews were recorded and transcribed using the NVivo analysis software. A thematic analysis led to a categorization of all the verbatims. ResultsHospital doctors are reluctant to deprescribe drugs initiated by a colleague and feel that it is the responsibility of the general practitioner (GP), who fails to do so due to lack of time. In this situation, the hospital pharmacist is in the best position to deprescribe because of his/her expertise in drug therapy. This should be a discussion between the hospital pharmacist, the hospital doctor, the GP and the patient. Deprescribing should always be adapted to the patient's context. ConclusionHospital physicians are open to a pharmacist-mediated, patient-centred approach to deprescribing as long as the GP is involved.
引用
收藏
页码:718 / 728
页数:11
相关论文
共 39 条
[1]   Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis [J].
Anderson, Kristen ;
Stowasser, Danielle ;
Freeman, Christopher ;
Scott, Ian .
BMJ OPEN, 2014, 4 (12)
[2]  
[Anonymous], 2010, FRAM ACT INT ED COLL, DOI DOI 10.1128/JVI.76.8.4044
[3]   Deprescribing versus continuation of chronic proton pump inhibitor use in adults [J].
Boghossian, Taline A. ;
Rashid, Farah Joy ;
Thompson, Wade ;
Welch, Vivian ;
Moayyedi, Paul ;
Rojas-Fernandez, Carlos ;
Pottie, Kevin ;
Farrell, Barbara .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (03)
[4]  
Braun V, 2006, Qualitative Research in Psychology, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA, DOI 10.1080/10875549.2021.1929659]
[5]   Impact of Clinical Pharmacists' Recommendations on a Proton Pump Inhibitor Taper Protocol in an Ambulatory Care Practice [J].
Bundeff, Andrew W. ;
Zaiken, Kathy .
JOURNAL OF MANAGED CARE PHARMACY, 2013, 19 (04) :325-333
[6]  
Corden A., 2006, Social Research Methodology, V9, P97, DOI [10.1080/13645570600595264, DOI 10.1080/13645570600595264]
[7]  
Farrell B, 2017, CAN FAM PHYSICIAN, V63, P354
[8]   Using vignettes to collect data for nursing research studies: How valid are the findings? [J].
Gould, D .
JOURNAL OF CLINICAL NURSING, 1996, 5 (04) :207-212
[9]   How Many Focus Groups Are Enough? Building an Evidence Base for Nonprobability Sample Sizes [J].
Guest, Greg ;
Namey, Emily ;
McKenna, Kevin .
FIELD METHODS, 2017, 29 (01) :3-22
[10]  
Gundumogula M., 2020, INT J HUMANIT SOC ST, V8, DOI [10.24940/theijhss/2020/v8/i11/HS2011-082, DOI 10.24940/THEIJHSS/2020/V8/I11/HS2011]